About Protenus
Protenus is a Healthcare company based in Baltimore (United States) founded in 2014, and was acquired by Bluesight in January 2025. AI-based insider threat detection and prevention solutions for healthcare sector. Protenus has raised $61 million across 8 funding rounds from investors including Bluesight, Cognosante and MemorialCare Health System. The company has 95 employees. Protenus offers products and services including RFID Medication Management, KitCheck Anywhere, ControlCheck, CostCheck, and Patient Privacy Monitoring. Its focus areas include HealthTech, Healthcare IT, Provider and Administrative Solutions. Its competitors include Imprivata, Datavant and Clearwave; 3 of its 3 listed competitors have raised funding.
Company details
Protenus was founded in 2014 in Baltimore, United States, with operations centered on the healthcare sector. AI-driven solutions are offered to monitor electronic medical record access in real time, identifying deviations from institutional baselines to address insider threats. Integration with existing hospital systems is facilitated, alongside visualization of clinical and administrative workflows. Employee behavior is tracked to enhance patient privacy and reduce risks of legal and financial penalties.
- Headquarters Baltimore, United States
- Employees 95
- Stage Acquired
- SectorsHealthcare
- Website protenus.com
- Social LinkedIn X
- Acquired by Bluesight (Jan 2025)
Products & Services of Protenus
Protenus offers a comprehensive portfolio of products and services, including RFID Medication Management, KitCheck Anywhere, ControlCheck, CostCheck, and Patient Privacy Monitoring.
Automates restocking and tracking of medications in hospitals.
Proactively detects and addresses drug diversion in healthcare settings.
Modernizes drug purchasing processes for retail efficiency.
Optimizes drug spend and ensures 340B program adherence.
Identifies privacy violations to strengthen healthcare compliance.
Funding Insights of Protenus
Protenus has successfully raised a total of $61M across 8 strategic funding rounds. The most recent funding activity was a Series D round of $21 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $61M
- Total Rounds 8
- Last Round Series D — $21M
- First Round $80,000
(May 2014)
- Investors Count 13
All 8 funding rounds of Protenus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2021 | $21M | Series D | – | – | |
| May 2019 | $17M | Series C | – | Transformation Capital | |
| Jan 2018 | $11M | Series B | – | F-Prime Capital, Kaiser Permanente Ventures | |
| Jul 2017 | $7M | Series A | – | Kaiser Permanente Ventures | |
| Feb 2016 | $4M | Series A | – | Arthur Ventures | |
| Mar 2015 | $150,000 | Seed | – | TEDCO | |
| Sep 2014 | $770,000 | Seed | – | – | – |
| May 2014 | $80,000 | Seed | – | – | – |
14 investors in total: 14 institutional.
Investors in Protenus
Protenus has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include Bluesight, Cognosante and MemorialCare Health System.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare startups are funded by this venture capital firm. | transformcap.com | Boston, United States | ||
Investments in life sciences, technology, healthtech, and crypto sectors from global locations. | fprimecapital.com | |||
Tech and Life Sciences focused corporate VC firm investing in the US | kpventures.com | Oakland, United States | ||
US focused seed & early stage VC firm | arthurventures.com | Minneapolis, United States | ||
Venture capital investing with a focus on diversity and inclusion in the ecosystem. | gaingels.com | |||
Early-stage healthcare investments are managed by LionBird venture capital firm. | lionbird.com | Tel Aviv, Israel | ||
Venture capital firm | allumiaventures.com | Seattle, United States | ||
| baltimoreangels.com | ||||
Startup accelerator | dreamit.com | New York, United States | ||
Venture capital fund and startup accelerator programs focused on seed and early stage companies | 1998 | tedcomd.com | Columbia, United States |
Investor details for Protenus
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Protenus
4 dated milestones of Protenus across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Protenus is founded.
- Funding First funding round of $80K.
- Funding Latest funding round, Series D, of $21.0M.
- Exit Acquired by Bluesight.
Competitors of Protenus
Protenus has 3 listed competitors in our database, 3 of them funded. They include Imprivata, Datavant and Clearwave.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| imprivata.com | 2002 | Waltham, United States | $40.5M | 546 | Cloud-based authentication and secure communication solutions are provided for enterprises. | |
| datavant.com | 2017 | San Francisco, United States | $80.5M | Secure patient data access is enabled through a healthcare platform. | ||
| clearwaveinc.com | 2004 | Atlanta, United States | $5.3M | 27 | Clearwave is recognized as a leading patient revenue platform. |
Detailed competitors of Protenus
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Protenus (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Protenus
Complete news archive for Protenus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Protenus
Protenus was founded in 2014.
Protenus is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
Protenus is a funded company, having raised a total of $61M across 8 funding rounds to date. The company's 1st funding round was a Seed of $80K, raised on May 2014.
Protenus has 95 employees.
Protenus was founded in 2014 in Baltimore, United States, with operations centered on the healthcare sector. AI-driven solutions are offered to monitor electronic medical record access in real time, identifying deviations from institutional baselines to address insider threats. Integration with existing hospital systems is facilitated, alongside visualization of clinical and administrative workflows. Employee behavior is tracked to enhance patient privacy and reduce risks of legal and financial penalties.
Protenus offers RFID Medication Management, KitCheck Anywhere, ControlCheck, CostCheck, and Patient Privacy Monitoring.
Protenus has 14 investors. Key investors include Bluesight, Cognosante, MemorialCare Health System, TEDCO, and Transformation Capital.
Yes. Protenus was acquired by Bluesight in January 2025.